The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Oncolytics Biotech

  • ONC
  • TSX
  • Consumer Products
  • Latest 1.12
  • Currency C$
  • Change 0.21
  • Percent Change 23.077 %
  • Volume 608,888
  • Fri Oct 31, 2014 03:59 PM EDT TSX data delayed 15 minutes.
  • Open 0.99
  • Previous Close 0.91
  • High 1.23
  • Low 0.98
  • Bidx14,000 1.05
  • Askx500 1.12
  • 52-week High10/31 2.89
  • 52-week Low10/10 0.445
  • Beta 1.359
  • Market Cap 98.04M
  • EPS -0.25
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $329,398
  • Earnings $-22,109,744
  • Return on Equity n/a

Cash Flow

  • Cash Flow $-21,147,826
  • Cash $16,880,730
  • Current Ratio 5.34

12 months ended Jun 30, 2014.

Trailing 12 month results shown above.
All data is in Canadian dollars.

Balance Sheet

  • Assets $20,046,561
  • Liabilities $3,667,076
  • Liabilities-to-Equity Ratio 0.22

Price Ratios

  • Price to Sales 294.39
  • Price to Book 5.89
  • Price to Cash Flow -4.59

Event Calendar

Event Last   Next  
Earnings Aug 7 $-0.07 Nov 6 $-0.07
Surprises Aug 7 -28.57% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Oct 31, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

ONCOLYTICS BIOTECH INC. is a biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN, its proprietary formulation of the human reovirus.

Related Securities
Symbol Type Latest % Chg

Officers

  • Bradley G. Thompson President & C.E.O. & Chairman
  • Douglas A. Ball C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: n/a
  • Incorporation: Canada,
    Apr 2, 1998
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

Suite 210
Calgary, AB
T2N 1X7

Phone: (403)-670-7377
Fax: (403)-2830858

info@oncolyticsbiotech.com
www.oncolyticsbiotech.com

Ideas & Discussion

Live Discussion of ONC on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.